Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01221532 · ClinicalTrials.gov registry record · NA

Support From Hospital to Home for Elders: A Randomized Controlled Study

A NA study of Hospital Readmissions, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
699
Enrollment target
1
Study location

NCT01221532: Completed NA study of Hospital Readmissions, sponsored by University of California, San Francisco.

NCT01221532 is a NA study of Hospital Readmissions that has completed, run by University of California, San Francisco. The registered enrollment target is 699 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01221532, a NA study of Hospital Readmissions, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
699 participants
Enrollment target
1
Study location

Study Summary

The investigators will randomize 700 non-psychiatric, non-obstetric, non-surgical patients aged 55 years and older at San Francisco General Hospital (SFGH) to usual care (ten days of prescription medication, discharge summary sent to primary care provider (PCP), and outpatient appt made for patient, and patient's nurse reviews discharge plan,) or usual care plus a peridischarge intervention (a visit with specialized in-hospital discharge nurse, development of personalized discharge plan, two phone calls from a nurse practitioner(NP)/physician assistant (PA) after discharge and availability of additional calls back from NP/PA, upon patient request, to help answer questions and assist patient's transition to outpatient care, and communication with primary care/subspecialty providers). The usual care and usual care plus intervention groups will be assessed for differences in mortality and rates of rehospitalization and emergency department use 30, 90 and 180 days following discharge from the hospital. The discharge process from the hospital to home is frequently marked by poor quality and high risk of adverse events and readmissions. It has been hypothesized that better coordinated care, personalized patient education, and follow-up calls to identify potential sources of adverse events, such as medical complications and medication errors can reduce rehospitalization and emergency room visits following discharge from the hospital. Although these interventions have been shown to reduce combined hospital readmissions and emergency department visits in English-speaking patients, none has focused on elderly patients in a diverse urban public hospital setting that includes non-English-speakers, who might benefit more than other populations from enhanced services during and after discharge from the hospital. Further, these labor-intensive interventions are costly to implement, and it is unknown whether opportunity cost of providing additional services in a limited-resource e

Conditions Studied

Interventions

  • BEHAVIORAL SHHE Peridischarge Intervention

Study Locations (1)

California

  • San Francisco General Hospital - San Francisco

Trial Details

FieldValue
Enrollment Target 699 participants
Start Date 2010-07
Est. Completion 2013-07
Phase NA

What the finished NCT01221532 record still lists

NCT01221532 is an interventional study that assigns participants to a tested intervention. The registered 699 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (50% lower).

The record links to 1 condition, with Hospital Readmissions appearing as the primary indexed condition, and to 1 intervention - of which SHHE Peridischarge Intervention is the first listed.

NCT01221532 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01221532 about?

NCT01221532 is a clinical study titled "Support From Hospital to Home for Elders: A Randomized Controlled Study". The investigators will randomize 700 non-psychiatric, non-obstetric, non-surgical patients aged 55 years and older at San Francisco General Hospital (SFGH) to usual care (ten days of prescription medication, discharge summary sent to primary care provider (PCP), and outpatient appt made for patient,...

What is the current status of trial NCT01221532?

This trial is currently completed. It is a NA study. The enrollment target is 699 participants. The study started on 2010-07. Estimated completion is 2013-07.

What conditions does trial NCT01221532 study?

This clinical trial studies the following conditions: Hospital Readmissions.

What interventions are being tested in trial NCT01221532?

The interventions under investigation include: SHHE Peridischarge Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01221532?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01221532 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hospital Readmissions

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01221532's enrollment target sits among peer trials

699 151st of 2000 higher than 1,850 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07187115 · 699 participants · NA

    A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation

  • NCT00900419 · 700 participants

    Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers

  • NCT01804686 · 700 participants · Phase 3

    A Long-term Extension Study of PCI-32765 (Ibrutinib)

  • NCT02107989 · 700 participants

    Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01221532, the US trial registry maintained by the National Library of Medicine. NCT01221532 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.